Dibasic aminoaciduria type 1

Dibasic Aminoaciduria Type 1 is a rare genetic disorder characterized by the body's inability to properly reabsorb certain amino acids during the filtering process in the kidneys. This condition leads to an increased excretion of specific dibasic amino acids, namely lysine, arginine, and ornithine, in the urine. Dibasic Aminoaciduria Type 1 is caused by mutations in the SLC3A1 gene, which encodes a component of the amino acid transporter system in the kidney.

Causes

The primary cause of Dibasic Aminoaciduria Type 1 is mutations in the SLC3A1 gene. This gene plays a crucial role in the renal reabsorption of dibasic amino acids. Mutations in SLC3A1 disrupt the normal function of the transporter, leading to the excessive loss of lysine, arginine, and ornithine in the urine.

Symptoms

Most individuals with Dibasic Aminoaciduria Type 1 are asymptomatic, meaning they do not exhibit any overt symptoms directly attributable to the disorder. However, the condition can be identified through urine tests that reveal elevated levels of dibasic amino acids.

Diagnosis

Diagnosis of Dibasic Aminoaciduria Type 1 typically involves a combination of urine analysis and genetic testing. Urine analysis can detect the increased excretion of dibasic amino acids, while genetic testing can identify mutations in the SLC3A1 gene.

Treatment

As most cases of Dibasic Aminoaciduria Type 1 are asymptomatic, specific treatment is often not required. Management of the condition usually focuses on monitoring amino acid levels in the urine and ensuring overall kidney health. In rare cases where symptoms do occur, treatment is symptomatic and supportive.

Prognosis

The prognosis for individuals with Dibasic Aminoaciduria Type 1 is generally favorable, as the condition often does not lead to kidney damage or other serious health issues. With appropriate monitoring, most affected individuals can lead normal, healthy lives.

This metabolic disorder related article is a stub. You can help WikiMD by expanding it.